These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4048981)

  • 1. Intraperitoneal chemotherapy: technical experience at five institutions.
    Piccart MJ; Speyer JL; Markman M; ten Bokkel Huinink WW; Alberts D; Jenkins J; Muggia F
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):90-6. PubMed ID: 4048981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].
    de Graaf PW; ten Bokkel Huinink WW; Aartsen EJ; Mellema MM; Dubbelman R; Hart AA
    Ned Tijdschr Geneeskd; 1987 Feb; 131(8):323-6. PubMed ID: 3561578
    [No Abstract]   [Full Text] [Related]  

  • 3. Peritoneal access for intracavitary chemotherapy.
    Howell SB; Pfeifle CE
    Cancer Drug Deliv; 1986; 3(2):157-61. PubMed ID: 3708538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
    Emerich J; Milczek T; Debniak J; Majdak E
    Ginekol Pol; 2002 Nov; 73(11):1103-8. PubMed ID: 12722406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
    Milczek T; Emerich J; Klasa-Mazurkiewicz D
    Ginekol Pol; 2003 Sep; 74(9):817-23. PubMed ID: 14674130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
    Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
    Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience of a subcutaneously implantable drug delivery catheter (PORT-A-CATH)].
    Kimura K; Koide A; Suga S; Shimoyama T; Okamoto E; Utsunomiya J; Okawa T; Taguchi T; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1150-5. PubMed ID: 3566308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter.
    Jenkins J; Sugarbaker PH; Gianola FJ; Myers CE
    Surg Gynecol Obstet; 1982 Jun; 154(6):858-62. PubMed ID: 7079929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified technique for insertion of intraperitoneal port for chemotherapy.
    Liou WS; Teng NN; Chan JK
    J Surg Oncol; 2005 Jun; 90(4):247-8. PubMed ID: 15906367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal therapy in renal failure.
    Twardowski ZJ
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):81-9. PubMed ID: 3901270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Totally implantable system for peritoneal access.
    Pfeifle CE; Howell SB; Markman M; Lucas WE
    J Clin Oncol; 1984 Nov; 2(11):1277-80. PubMed ID: 6491705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
    Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
    Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
    Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
    Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.
    Topuz E; Salihoglu Y; Aydiner A; Saip P; Tas F; Sozen T; Berkman S; Bengisu E
    J Surg Oncol; 2000 Jul; 74(3):223-6. PubMed ID: 10951423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administering intraperitoneal chemotherapy using a peritoneal port.
    Doane LS
    Nurs Clin North Am; 1993 Dec; 28(4):885-97. PubMed ID: 8265427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications associated with intraperitoneal chemotherapy catheters.
    Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
    Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functioning of implantable catheters of intraperitoneal chemotherapy].
    de Gramont A; Marpeau L; Demuynck B; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J; Couturier JY; Delfau S
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):381-5. PubMed ID: 1869783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bowel injury caused by a catheter for Intraperitoneal chemotherapy--a case report].
    Yamauchi I; Higashi M; Yoshioka M; Koyama N; Hashimoto M; Takahashi K; Nakamura Y
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1713-6. PubMed ID: 8886051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ports and complications for intraperitoneal chemotherapy delivery.
    Helm CW
    BJOG; 2012 Jan; 119(2):150-9. PubMed ID: 22017885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.